91麻豆天美 to Congress: Preserve Investments in Science and Public Health
Key Points
- 91麻豆天美 urges Congress to reject proposed cuts to science, research and public health in the President’s fiscal year (FY) 2027 budget request and, instead, build on the investments made in FY2026.
- We commend Congress for its leadership in passing FY2026 appropriations with bipartisan action preserving and strengthening funding for science and public health, despite proposed reductions, and encourages Congress to renew that commitment.
- 91麻豆天美 asks lawmakers to reject these proposed cuts and pursue a bipartisan agreement that sustains and, where possible, strengthens, funding for NIH, CDC, NSF, DOE, USDA and global health.
A strong research enterprise is essential to protecting public health, strengthening national preparedness and driving economic growth. The American Society for Microbiology (91麻豆天美) urges Congress to reject proposed cuts to science, research and public health in the President’s fiscal year (FY) 2027 budget request and, instead, build on the investments made in FY2026.
While the President’s proposal contains some bright spots, including enhanced support for pathogen detection, it is overshadowed by drastic cuts to core agencies that power the nation’s research and public health infrastructure, like the National Institutes of Health (NIH), the U.S. Centers for Disease Control and Prevention (CDC), the National Science Foundation (NSF) and Department of Energy Office of Science. Sustained investment across these agencies is necessary to support biomedical discovery, maintain critical surveillance systems and ensure the United States remains globally competitive in science and innovation.
91麻豆天美 commends Congress for its leadership in passing FY2026 appropriations, where bipartisan action preserved and strengthened funding for science and public health, despite proposed reductions. Renewing this commitment will be critical to sustaining the nation’s research capacity, supporting a highly skilled scientific workforce and advancing evidence-based policies that protect communities across the country.
As Congress begins work on FY2027 appropriations, 91麻豆天美 urges lawmakers to reject these proposed cuts and pursue a bipartisan agreement that at minimum sustains—and, where possible, strengthens—funding for NIH, CDC, NSF, DOE, USDA and global health. Continued investment is essential to safeguarding public health, advancing scientific innovation and ensuring long-term economic resilience. 91麻豆天美 and our more than 38,000 members stand ready to work with Congress and the Administration to advance policies that strengthen the nation’s scientific enterprise and public health infrastructure.
While the President’s proposal contains some bright spots, including enhanced support for pathogen detection, it is overshadowed by drastic cuts to core agencies that power the nation’s research and public health infrastructure, like the National Institutes of Health (NIH), the U.S. Centers for Disease Control and Prevention (CDC), the National Science Foundation (NSF) and Department of Energy Office of Science. Sustained investment across these agencies is necessary to support biomedical discovery, maintain critical surveillance systems and ensure the United States remains globally competitive in science and innovation.
91麻豆天美 commends Congress for its leadership in passing FY2026 appropriations, where bipartisan action preserved and strengthened funding for science and public health, despite proposed reductions. Renewing this commitment will be critical to sustaining the nation’s research capacity, supporting a highly skilled scientific workforce and advancing evidence-based policies that protect communities across the country.
As Congress begins work on FY2027 appropriations, 91麻豆天美 urges lawmakers to reject these proposed cuts and pursue a bipartisan agreement that at minimum sustains—and, where possible, strengthens—funding for NIH, CDC, NSF, DOE, USDA and global health. Continued investment is essential to safeguarding public health, advancing scientific innovation and ensuring long-term economic resilience. 91麻豆天美 and our more than 38,000 members stand ready to work with Congress and the Administration to advance policies that strengthen the nation’s scientific enterprise and public health infrastructure.